| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000003868 |
| Receipt No. | R000004286 |
| Official scientific title of the study | Effect of acarbose on amelioration of endothelial function evaluated by FMD in type 2 diabetic patients. |
| Date of disclosure of the study information | 2011/03/31 |
| Last modified on | 2017/01/08 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Effect of acarbose on amelioration of endothelial function evaluated by FMD in type 2 diabetic patients. | |
| Title of the study (Brief title) | Acarbose-FMD clinical trial | |
| Region |
|
|
| Condition | ||
| Condition | type 2 diabetes mellitus | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To compare the protective effects of acarbose and voglibose on endothelial function evalutaed by FMD in type 2 diabetes patients. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Flow Mediated Dilation test |
| Key secondary outcomes | HbA1c, fasting blood glucose/triglyceride and postprandial (2h) blood glucose/triglyceride, LDL-cholesterol, HDL-cholesterol, urinary albumin extraction, body weight, blood pressure |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | acarbose 150-300 mg/day | |
| Interventions/Control_2 | voglibose 0.9 mg/day | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Type 2 diabetic patients who have been treated with voglibose 0.9 mg/day for 3 months or more.
2)HbA1c of 6.5%(NGSP) or more. |
|||
| Key exclusion criteria | 1)Patients with ACS within 6 months
2)Patie nts treating with insulin 3)Patients who have undergone a gastrectomy or abdominal surgery 4)Patients with sever hepatic dysfunction or renal dysfunction 5)Patients with serious ketosis, diabetic coma, pre-coma 6)Patients with sever infection, pre-/after recent operation , serious trauma 7)Patients with gastrointestinal disorders such as diarrhea and vomitting 8)Patients with history of sensitivity to acarbose 9)Women who are pregnant or with a possibility of pregnancy 10)Other patients whom the investigator deems unsuitable for inclusion in this study |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Eitaro Nakashima |
| Organization | Chubu Rousai Hospital |
| Division name | Dept. of Diabetes and Endocrinology |
| Address | 1-10-6 Koumei, Minato-ku, Nagoya |
| TEL | +81-52-652-5511 |
| eitaro@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Eitaro Nakashima |
| Organization | Chubu Rousai Hospital |
| Division name | Dept. of Diabetes and Endocrinology |
| Address | 1-10-6 Koumei, MInato--ku, Nagoya |
| TEL | 052-652-5511 |
| Homepage URL | |
| eitaro@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Chubu Rousai Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Chubu Rosai Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | None |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 中部労災病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000004286 |